| SpectraBase Spectrum ID |
DkB7g5ZzD0a |
| Name |
1,4-Di-(3-bromobenzyl)piperazine |
| Classification |
Piperazine designer drug |
| Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| Exact Mass |
421.999324652 u |
| Formula |
C18H20Br2N2 |
| InChI |
InChI=1S/C18H20Br2N2/c19-17-5-1-3-15(11-17)13-21-7-9-22(10-8-21)14-16-4-2-6-18(20)12-16/h1-6,11-12H,7-10,13-14H2 |
| InChIKey |
KYUSTKYOXPSKCA-UHFFFAOYSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
424.180 g/mol |
| Nominal Mass |
422 u |
| Quality |
993 |
| Retention Index |
2805 |
| SMILES |
C=1(CN2CCN(CC=3C=C(C=CC3)Br)CC2)C=C(C=CC1)Br |
| SPLASH |
splash10-0v4j-4980000000-de7779f5f9b8207d9569 |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
Piperazine,1,4-di-(3-bromobenzyl)
1,4-bis(3-bromobenzyl)piperazine |
| Technique |
GC/MS |
| Wiley ID |
DD2024_011135 |
